Fingolimod Capsule
Product Images NDC 42291-048

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fingolimod (NDC 42291-048). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30 (048 30)

Fingolimod Capsules 0.5 mg oral capsule label from AvKARE. The label includes the product name, strength, quantity of 30 capsules, and instructions to dispense the accompanying medication guide. Storage conditions and manufacturing information are also provided, along with a QR code and barcode.*

FDA Label Image

Structure (Image 1)

Chemical structure of Fingolimod hydrochloride showing its molecular formula C19H33NO2•HCl with the depicted arrangement of atoms and bonds.*

FDA Label Image

Figure-revised (Image 2)

A line graph showing the percentage of patients with three-month confirmed progression over time in days. The graph compares Fingolimod 0.5 mg treatment (solid line) versus placebo (dashed line), indicating lower progression percentages with Fingolimod throughout the study period up to approximately 720 days.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.